| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |